万孚生物: 广州万孚生物技术股份有限公司章程（2025年6月）

General Provisions - Guangzhou Wondfo Biotech Co., Ltd. aims to protect the legal rights of the company, shareholders, and creditors while regulating its organization and behavior according to relevant laws and regulations [1] - The company was established as a joint-stock company and registered with the Guangzhou Administration for Industry and Commerce [1] - The company was approved by the China Securities Regulatory Commission for its initial public offering of 22 million shares on June 30, 2015 [1] - The registered capital of the company is RMB 468,084,354 [1] Business Objectives and Scope - The company's business objective is to become a competitive manufacturer in the rapid in vitro diagnostic industry (POCT) and to provide services for public health [1] - The registered business scope includes the production and sale of medical devices, software development, artificial intelligence applications, and various consulting services [1] Shares - The company's shares are issued in the form of stocks with a par value of RMB 1 per share [2] - The total number of shares currently issued by the company is 468,084,354 [4] - The company cannot provide financial assistance for the purchase of its shares [4] Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends, participate in shareholder meetings, supervise the company's operations, and transfer their shares [6] - Shareholders must comply with laws and the company's articles of association, and they are responsible for paying their subscribed capital [8] - Shareholders holding more than 5% of voting shares must report any pledges of their shares to the company [9] Shareholder Meetings - The company holds annual and extraordinary shareholder meetings to decide on key matters such as business direction, capital changes, and profit distribution [10] - The notice for shareholder meetings must be sent out at least 20 days in advance for annual meetings and 15 days for extraordinary meetings [15] - The resolutions passed in shareholder meetings require a majority or two-thirds majority vote depending on the type of resolution [75][76]